FREQUENCY OF DYSLIPIDEMIA IN PATIENTS HAVING TYPE 2 DIABETES MELLITUS PRESENTING TO MEDICAL OPD/EMERGENCY IN KHYBER TEACHING HOSPITAL PESHAWAR
Main Article Content
Keywords
Dyslipidemia, Type 2 Diabetes Mellitus, Khyber Teaching Hospital, Peshawar
Abstract
Background: Dyslipidemia is an important modifiable risk factor for cardiovascular disease among patients of type 2 diabetes mellitus. Timely detection and characterization of this condition help clinicians estimate future risk of cardiovascular disease and take appropriate preventive measures. The aim of this study was to determine the prevalence of dyslipidemia in a cohort patient with type 2 diabetes mellitus presenting to OPD/emergency in department of General Medicine in Khyber Teaching Hospital Peshawar.
MATERIAL AND METHODS: A cross sectional descriptive study was conducted among the patients of Type 2 Diabetes mellitus presenting to OPD/emergency in department of General Medicine in Khyber Teaching Hospital Peshawar. The study was conducted from January 2022 to June 2022 over a period of six months. All
Results: I found mixed dyslipidemia as the most prevalent (88.1%) and isolated dyslipidemia (10.1%) as the least prevalent forms of dyslipidemia in our patients. The most prevalent form of single dyslipidemia was high LDL-C (73.8%) and combined dyslipidemia was high TG, high LDL-C and low HDL-C (44.7%). Prevalence of all single and mixed dyslipidemia was higher in patients with poor glycemic control and hypertension. The glycemic status of patients correlated with their fasting serum lipid profile. Dyslipidemia was associated mainly with male gender, poor glycemic control and hypertension
Conclusion: It shows that dyslipidemia is associated mainly with male gender, poor glycemic control and hypertension. It is highly prevalent in patients with type 2 diabetes. Urgent lifestyle modification, sustained glycemic control and aggressive lipid lowering treatment plans are necessary to minimize the future risk of cardiovascular disease in this population
References
2. Rana AK, Ray S. Dyselectrolytemia in hyperglycaemic crisis patients with uncontrolled non-insulin dependent diabetes mellitus. Int J Res Med Sci. 2017;5:478-81
3. Ni WQ, Liu XL, Zhuo ZP. Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen. Lipids Health Dis. 2015;14:71
4. Manjunath CN, Rawal JR, Irani PM, Madhu K. Atherogenic dyslipidemia. Indian J EndocrinolMetab. 2013;17(6):969–96
5. Bali K, Vij AS. Pattern of dyslipidemia in type 2 diabetes mellitus in Punjab. Int J Res Med Sci. 2016;4:809-12
6. Iqbal A, Asif M, Qadir MI. Modern technologies in the management of diabetes. J Coll Med Sci Nepal. 2017;13(2):296-301
7. Sarfraz M, Sajid S, Ashraf MA. Prevalence and pattern of dyslipidemia in hyperglycemic patients and its associated factors among Pakistani population. Saudi J Bio Sci. 2016;23:761–6
8. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) JAMA. 2001;285:2486–97
9. Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Type 2 diabetes as a “coronary heart disease equivalent”: an 18-year prospective population-based study in Finnish subjects. Diabetes Care. 2005;28:2901–7
10. Eliasson B, Cederholm J, Eeg-Olofsson K, Svensson AM, Zethelius B, Gudbjörnsdottir S, National Diabetes Register Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes. Diabetes Care. 2011;34:2095–2100
11. Pokharel DR, Khadka D, Sigdel M, Yadav NK, Acharya S, Kafle RC, Shukla PS. Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and Harmonized criteria. J Diabetes Metab Disord. 2014;13:104
12. Hwang Y-C, Ahn H-Y, Lee WJ, Park C-Y, Park SW. An equation to estimate the concentration of serum apolipoprotein B. PLoS ONE. 2012;7:e51607
13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, et.al., National High Blood Pressure Education Program Coordinating Committee The Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–72
14. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF Consultation. Geneva: World Health Organization; 2006. p. 39
15. Pandeya A, Sharma M, Regmi P, Basukala A, Lamsal M. Pattern of dyslipidemia and evaluation of non-HDL cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus. Nepal Med Coll J. 2012;14:278–82
16. Bhandari GP, Angdembe MR, Dhimal M, Neupane S, Bhusal C. State of non-communicable diseases in Nepal. BMC Public Health. 2014;14:23
17. Aljabri KS, Bokhari SA, Akl A. The relation between overweight, obesity and plasma lipids in Saudi adults with type 2 diabetes. J Health Spec. 2016;4:140–45
18. Ali F, Jamil H, Anwar SS, Wajid N. Characterization of lipid parameters in diabetic and non-diabetic atherosclerotic patients. J Geriatr Cardiol. 2015;12:37–43
19. Chang JB, Chu NF, Syu JT, Hsieh AT, Hung YR. Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients. Lipids Health Disease. 2011;10:228
20. Wilson PWF, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDLC with age: the Framingham study. J Gerontol. 1994;49
21. Betteridge DJ. Lipid control in patients with diabetes mellitus. Nat Rev Cardiol. 2011;8:278–90
22. Nepal Health Research Council (NHRC). Prevalence of non-communicable diseases in Nepal-Hospital based study. A study report published by NHRC, Ram Shah Path, Kathmandu, Nepal, December, 2010
23. Kimm H, Lee SW, Lee HS, Shim KW, Cho CY, Yun JE, Jee SH. Associations between lipid measures and metabolic syndrome, insulin resistance and adiponectin–usefulness of lipid ratios in Korean men and women. Circ J. 2010;2010(74):931–7
24. Walter M. Interrelationships among HDL Metabolism, aging and atherosclerosis. Arterioscleroses Thrombi Vass Boil. 2009;29:1244–50
25. Shrewastwa MK, Thanpari C, Yadav NK, Mittal RK, Rohil V. Dyslipidemia in type 2 diabetes mellitus patients in western of Nepal: a hospital based study. Bali Med J. 2013;2:46–50
26. Karim MN, Ahmed KR, Bukht MS, Akter J, Chowdhury HA, Hossain S, Anwar N, Selim S, Chowdhury SH, Hossain F, Ali L. Pattern and predictors of dyslipidemia in patients with type 2 diabetes mellitus. Diabetes Metab Syndr. 2013;7:95–100
27. Jayarama N, Reddy M, Lakshmaiah V. Prevalence and pattern of dyslipidemia in type 2 diabetes mellitus patients in a rural tertiary care centre, southern India. Glob J Med Public Health. 2012;1:24–7
28. Pokharel DR, Khadka D, Sigdel M, Yadav NK, Sapkota LB, Kafle RC, Nepal S, Sapkota RM, Chaudhary N. Estimation of 10-year risk of coronary heart disease in Nepalese patients with type 2 diabetes: Framingham versus United Kingdom Prospective Diabetes Study. North Am J Med Sci. 2015;7:347–355
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Tanveer Ul Haq
SPR medical ICU Hayatabad Medical Complex Peshawar
Muhammad Awais khan
Medical officer medical ICU Hayatabad Medical Complex Peshawar
Saad karim
Medical B ward Hayatabad Medical Complex Peshawar
Hamza Hussain
TMO Hayatabad Medical Complex Peshawar
Fazal Ghani
TMO Hayatabad Medical Complex Peshawar
Najeeb ullah
Consultant MERF khyber Cat D hospital bazar Zakha khel
Mohammad zubair khan
Medical officer neurology Hayatabad Medical Complex Peshawar